Gene silencing of cardiovascular genes
GB2702002APending Publication Date: 2026-05-27ARGONAUTE RNA LTD
Patent Information
- Application Number
- GB2025017302
- Authority / Receiving Office
- GB · GB
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-07-03
- Filing Date
- 2025-10-17
- Publication Date
- 2026-05-27
Abstract
A bispecific nucleic acid molecule comprising at least two double stranded inhibitory ribonucleic acid (RNA) molecules that silence by RNA interference apolipoprotein B (ApoB) and diacylglycerol O acyltransferase 2 (DGAT2) wherein said at least two double stranded inhibitory RNA molecules are linked by a DNA linker molecule that has a melting temperature (TM) of approximately 73oC. The use of such dual siRNA constructs in treating cardiovascular related conditions including hypercholesterolemia is further claimed. [Fig. 2A]
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Treatment of cardiovascular disease
GB2618915A
Multi-targeted single entity conjugates
WO2017015109A1
Treatment of cardiovascular disease
WO2022136466A1